Home/Indian Immunologicals/Dr. K. Anand Kumar
DK

Dr. K. Anand Kumar

Managing Director

Indian Immunologicals

Therapeutic Areas

Indian Immunologicals Pipeline

DrugIndicationPhase
AbhayrabHuman RabiesApproved
Hepatitis A VaccineHuman Hepatitis AApproved
Porcine Cysticercosis VaccinePorcine CysticercosisApproved
gE‑Deleted DIVA Marker VaccineInfectious Bovine Rhinotritis (IBR)Approved
Bi‑valent Human Monoclonal Antibody for RabiesHuman Rabies Post‑Exposure ProphylaxisPhase 1